McCormack LJ - Search Results

1

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.

McCormack LJ, Nagi DK, Stickland MH, Mansfield MW, Mohamed-Ali V, Yudkin JS, Knowler WC, Grant PJ. McCormack LJ, et al. Diabetologia. 1996 Dec;39(12):1512-8. doi: 10.1007/s001250050606. Diabetologia. 1996. PMID: 8960834

2

The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians.

Foy CA, McCormack LJ, Knowler WC, Barrett JH, Catto A, Grant PJ. Foy CA, et al. Among authors: mccormack lj. J Med Genet. 1996 Apr;33(4):336-7. doi: 10.1136/jmg.33.4.336. J Med Genet. 1996. PMID: 8730292 Free PMC article.

3

Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.

Nagi DK, McCormack LJ, Mohamed-Ali V, Yudkin JS, Knowler WC, Grant PJ. Nagi DK, et al. Among authors: mccormack lj. Diabetes Care. 1997 Aug;20(8):1304-9. doi: 10.2337/diacare.20.8.1304. Diabetes Care. 1997. PMID: 9250459

4

The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells.

McCormack LJ, Semple JI, Stickland MH, Barrett JH, Grant PJ. McCormack LJ, et al. Thromb Res. 1998 Dec 1;92(5):199-206. doi: 10.1016/s0049-3848(98)00132-7. Thromb Res. 1998. PMID: 9851810

5

The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.

Gough SC, Rice PJ, McCormack L, Chapman C, Grant PJ. Gough SC, et al. Diabet Med. 1993 Aug-Sep;10(7):638-42. doi: 10.1111/j.1464-5491.1993.tb00137.x. Diabet Med. 1993. PMID: 8403825

6

Apolipoprotein E polymorphism in cerebrovascular disease.

Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Bamford JM, Robinson P, Grant PJ. Catto AJ, et al. Among authors: mccormack lj. Acta Neurol Scand. 2000 Jun;101(6):399-404. doi: 10.1034/j.1600-0404.2000.90308a.x. Acta Neurol Scand. 2000. PMID: 10877158

7

Incidence of Arg506 --> Gln mutation (factor V Leiden) in Pima Indians.

Kohler HP, Boothby M, McCormack L, Knowler WC, Grant PJ. Kohler HP, et al. Thromb Haemost. 1997 Aug;78(2):961-2. Thromb Haemost. 1997. PMID: 9268205 No abstract available.

8

Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.

Mansfield MW, Kohler HP, Ariëns RA, McCormack LJ, Grant PJ. Mansfield MW, et al. Among authors: mccormack lj. Diabetes Care. 2000 May;23(5):703-5. doi: 10.2337/diacare.23.5.703. Diabetes Care. 2000. PMID: 10834435 No abstract available.

9

Prevalence of FXIII V34L in populations with different cardiovascular risk.

McCormack LJ, Kain K, Catto AJ, Kohler HP, Stickland MH, Grant PJ. McCormack LJ, et al. Thromb Haemost. 1998 Sep;80(3):523-4. Thromb Haemost. 1998. PMID: 9759641 No abstract available.

10

CCAAT/enhancer binding protein alpha, beta and delta gene variants: associations with obesity related phenotypes in the Leeds Family Study.

Bennett CE, Nsengimana J, Bostock JA, Cymbalista C, Futers TS, Knight BL, McCormack LJ, Prasad UK, Riches K, Rolton D, Scarrott T, Barrett JH, Carter AM. Bennett CE, et al. Among authors: mccormack lj. Diab Vasc Dis Res. 2010 Jul;7(3):195-203. doi: 10.1177/1479164110366274. Epub 2010 May 11. Diab Vasc Dis Res. 2010. PMID: 20460359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters